NYSE:MRT - MedEquities Realty Trust Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $10.59 -0.02 (-0.19 %) (As of 02/21/2019 12:57 PM ET)Previous Close$10.61Today's Range$10.48 - $10.6452-Week Range$6.27 - $11.85Volume57,176 shsAverage Volume382,894 shsMarket Capitalization$337.40 millionP/E Ratio9.29Dividend Yield3.93%Beta1.79 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment. Receive MRT News and Ratings via Email Sign-up to receive the latest news and ratings for MRT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustryN/A SectorFinance Current SymbolNYSE:MRT Previous Symbol CUSIPN/A Webwww.medequities.com Phone615-627-4710Debt Debt-to-Equity RatioN/A Current Ratio7.54 Quick Ratio7.54Price-To-Earnings Trailing P/E Ratio9.29 Forward P/E Ratio13.24 P/E GrowthN/A Sales & Book Value Annual Sales$61.10 million Price / Sales5.52 Cash Flow$1.1859 per share Price / Cash Flow8.93 Book Value$11.23 per share Price / Book0.94Profitability EPS (Most Recent Fiscal Year)$1.14 Net Income$20.42 million Net Margins19.98% Return on Equity3.39% Return on Assets1.97%Miscellaneous Employees12 Outstanding Shares31,860,000Market Cap$337.40 million OptionableNot Optionable MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions What is MedEquities Realty Trust's stock symbol? MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT." How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust? MedEquities Realty Trust declared a quarterly dividend on Thursday, August 2nd. Stockholders of record on Wednesday, August 15th will be paid a dividend of $0.21 per share on Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.93%. The ex-dividend date of this dividend is Tuesday, August 14th. View MedEquities Realty Trust's Dividend History. How were MedEquities Realty Trust's earnings last quarter? MedEquities Realty Trust Inc (NYSE:MRT) announced its quarterly earnings data on Wednesday, August, 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.30 by $0.20. The financial services provider had revenue of $17.56 million for the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. View MedEquities Realty Trust's Earnings History. What price target have analysts set for MRT? 9 equities research analysts have issued 1 year price targets for MedEquities Realty Trust's stock. Their forecasts range from $9.00 to $12.00. On average, they expect MedEquities Realty Trust's stock price to reach $10.6250 in the next year. This suggests a possible upside of 0.3% from the stock's current price. View Analyst Price Targets for MedEquities Realty Trust. What is the consensus analysts' recommendation for MedEquities Realty Trust? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust. What are Wall Street analysts saying about MedEquities Realty Trust stock? Here are some recent quotes from research analysts about MedEquities Realty Trust stock: 1. According to Zacks Investment Research, "MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. " (1/22/2019) 2. Cantor Fitzgerald analysts commented, "MRT reported in-line 4Q17 results and issued 2018 guidance that includes fewer acquisitions than we modeled, and we believe could be conservative. Closings have been slower industry-wide, but the backlog of announced deals is good for 2018." (2/21/2018) Has MedEquities Realty Trust been receiving favorable news coverage? News headlines about MRT stock have trended somewhat negative on Thursday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. MedEquities Realty Trust earned a news sentiment score of -1.7 on InfoTrie's scale. They also assigned media headlines about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. Who are some of MedEquities Realty Trust's key competitors? Some companies that are related to MedEquities Realty Trust include Kite Realty Group Trust (KRG), TIER REIT (TIER), TPG RE Finance Trust (TRTX), Redwood Trust (RWT), Saul Centers (BFS), Monmouth R.E. Inv. (MNR), Summit Hotel Properties (INN), PennyMac Mortgage Investment Trust (PMT), KKR Real Estate Finance Trust (KREF), American Finance Trust (AFIN), Interrent Real Estate Investment Trust (IIPZF), ARBOR RLTY TR I/SH (ABR), Easterly Government Properties (DEA), ARMOUR Residential REIT (ARR) and Ramco-Gershenson Properties Trust (RPT). Who are MedEquities Realty Trust's key executives? MedEquities Realty Trust's management team includes the folowing people: Mr. John W. McRoberts, Chairman & CEO (Age 66)Mr. William C. Harlan, Pres, COO & Director (Age 67)Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 49)Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 44)Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC When did MedEquities Realty Trust IPO? (MRT) raised $259 million in an IPO on Thursday, September 29th 2016. The company issued 19,900,000 shares at $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets served as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers. Who are MedEquities Realty Trust's major shareholders? MedEquities Realty Trust's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Prudential Financial Inc. (8.17%), BlackRock Inc. (5.54%), Nuveen Asset Management LLC (3.88%), Bank of New York Mellon Corp (1.31%), Geode Capital Management LLC (1.07%) and Dimensional Fund Advisors LP (0.45%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust. Which major investors are selling MedEquities Realty Trust stock? MRT stock was sold by a variety of institutional investors in the last quarter, including Martingale Asset Management L P, Nuveen Asset Management LLC, Bank of New York Mellon Corp, LSV Asset Management, Raymond James & Associates, Bessemer Group Inc., Janney Montgomery Scott LLC and Citigroup Inc.. View Insider Buying and Selling for MedEquities Realty Trust. Which major investors are buying MedEquities Realty Trust stock? MRT stock was acquired by a variety of institutional investors in the last quarter, including Prudential Financial Inc., D. E. Shaw & Co. Inc., BlackRock Inc., Raymond James Financial Services Advisors Inc., Dimensional Fund Advisors LP, Two Sigma Investments LP, Geode Capital Management LLC and California Public Employees Retirement System. Company insiders that have bought MedEquities Realty Trust stock in the last two years include John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust. How do I buy shares of MedEquities Realty Trust? Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is MedEquities Realty Trust's stock price today? One share of MRT stock can currently be purchased for approximately $10.59. How big of a company is MedEquities Realty Trust? MedEquities Realty Trust has a market capitalization of $337.40 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe. What is MedEquities Realty Trust's official website? The official website for MedEquities Realty Trust is http://www.medequities.com. How can I contact MedEquities Realty Trust? MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected] MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 173 (Vote Outperform)Underperform Votes: 207 (Vote Underperform)Total Votes: 380MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: How prevalent are 12b-1 fees?